Department of Radiation Oncology/Competence Center Palliative Care, University Hospital Zurich, Zurich, Switzerland,
Swiss Federal Institute of Technology, Wearable Computing Laboratory, Zurich, Switzerland.
Oncology. 2020;98(6):386-395. doi: 10.1159/000501433. Epub 2019 Jul 23.
Mobile health is a promising strategy aiming to anticipate and prevent the deterioration of health status in palliative cancer patients. A prerequisite for successful implementation of this technology into clinical routine is a high level of usability and acceptance of devices.
We aimed to evaluate feasibility as well as patients' acceptance of remote monitoring using wearables in palliative cancer patients.
In this prospective single-center observational feasibility study, 30 cancer patients treated with palliative intent in an inpatient setting with an estimated life expectancy of >8 weeks and <12 months were provided with a smartphone including a pre-installed "Activity Monitoring" app and a sensor-equipped bracelet and monitored over a period of 12 weeks starting at discharge from hospital. We report detailed feasibility and usability aspects and comment on patients' acceptance of the wearables.
Between February 2017 and May 2018 a total of 30 patients were included in the study. From these, 25 participants (83%) completed the whole study period. On average, the bracelet was worn on 53% and smartphone used on 85% of the study days. The completion rate of daily digital questionnaires for subjective ratings (pain and distress scale) was 73%, and 28 patients were able to handle the wearables and to operate the app without major problems. Use of the bracelet was low during the night hours, with a wearing time of 1.7% of all night hours (8 p.m. to 8 a.m.).
Remote monitoring of health care status in palliative cancer patients with a limited life expectancy is feasible and patients are able to handle the smartphone and the sensor-equipped bracelet. Feedback towards use of this monitoring system was mostly positive.
移动医疗是一种有前途的策略,旨在预测和预防癌症患者健康状况的恶化。将这项技术成功应用于临床常规的前提是设备具有较高的可用性和可接受性。
我们旨在评估在姑息治疗癌症患者中使用可穿戴设备进行远程监测的可行性和患者接受度。
在这项前瞻性单中心观察性可行性研究中,我们为 30 名接受姑息治疗的癌症住院患者提供了一部智能手机,其中预装有“活动监测”应用程序和带传感器的腕带,这些患者的预期寿命>8 周且<12 个月。从出院开始,我们对这些患者进行了为期 12 周的监测。我们报告了详细的可行性和可用性方面,并对患者对可穿戴设备的接受程度进行了评论。
2017 年 2 月至 2018 年 5 月期间,共有 30 名患者入组该研究。其中,25 名参与者(83%)完成了整个研究期间的监测。平均而言,腕带佩戴率为 53%,智能手机使用率为 85%。主观评分(疼痛和不适量表)的每日数字问卷完成率为 73%,且 28 名患者能够处理可穿戴设备并能够操作应用程序,没有出现重大问题。腕带在夜间的使用时间较低,所有夜间时间(晚上 8 点至早上 8 点)的佩戴时间仅为 1.7%。
在预期寿命有限的姑息治疗癌症患者中,对其健康状况进行远程监测是可行的,患者能够处理智能手机和带传感器的腕带。对该监测系统的使用反馈大多是积极的。